Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: A study using 24-h dual-channel pH-metry

References

• Bennett JR. Aetiology, pathogenesis, and clinical manifestations of gastro-oesophageal reflux disease. Scand J Gastroenterol 1988; 146 Suppl: 67–72
   Google Scholar
• Cadiot G, Bruhat A, Rigaud D, Coste T, Vuagnat A, Benyedder Y, et al. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut 1997; 40: 167–74
   PubMed Web of Science ®Google Scholar
• Armstrong D. Review article: gastric pH: the most relevant predictor of benefit in reflux disease? Aliment Pharmacol Ther 2004; 20 Suppl 5:19–26, discussion 38–9.
   PubMed Web of Science ®Google Scholar
• Bremner RM, Crookes PF, DeMeester TR, Peters JH, Stein HJ. Concentration of refluxed acid and esophageal mucosal injury. Am J Surg 1992;164:522–6, discussion 526–7.
   PubMed Web of Science ®Google Scholar
• Barlow AP, DeMeester TR, Ball CS, Eypasch EP. The significance of the gastric secretory state in gastroesophageal reflux disease. Arch Surg 1989; 124: 937–40
   PubMedGoogle Scholar
• Hirschowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 1991; 101: 1149–58
   PubMed Web of Science ®Google Scholar
• Collen MJ, Lewis JH, Benjamin SB. Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 1990; 98: 654–61
   PubMed Web of Science ®Google Scholar
• Collen MJ, Johnson DA, Sheridan MJ. Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy. Dig Dis Sci 1994; 39: 410–7
   PubMed Web of Science ®Google Scholar
• Gardner JD, Sloan S, Robinson M, Miner PB, Jr. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor. Aliment Pharmacol Ther 2004; 20: 1381–6
   PubMed Web of Science ®Google Scholar
• Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 1993; 104: 1511–7
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol EC, Meuwissen SG. Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990; 4: 485–95
   PubMed Web of Science ®Google Scholar
• Katz PO. Review article: Intragastric and esophageal pH monitoring in patients with gastroesophageal reflux disease. Aliment Pharmacol Ther 2006; 23 Suppl 1: 3–11
   PubMed Web of Science ®Google Scholar
• Peghini PL, Katz PO, Bracy NA, Castell DO. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998; 93: 763–7
   PubMed Web of Science ®Google Scholar
• Ours TM, Fackler WK, Richter JE, Vaezi MF. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol 2003; 98: 545–50
   PubMed Web of Science ®Google Scholar
• Fackler WK, Ours TM, Vaezi MF, Richter JE. Long-term effect of H2-RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 2002; 122: 625–32
   PubMed Web of Science ®Google Scholar
• Regan PT, Malagelada JR, Dimagno EP, Go VL. Postprandial gastric function in pancreatic insufficiency. Gut 1979; 20: 249–54
   PubMed Web of Science ®Google Scholar
• Kwiecien S, Konturek SJ. Gastric analysis with fractional test meals (ethanol, caffeine, and peptone meal), augmented histamine or pentagastrin tests, and gastric Ph recording. J Physiol Pharmacol 2003; 54 Suppl 3: 69–82
   PubMedGoogle Scholar
• Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023–9
   PubMed Web of Science ®Google Scholar
• Saraswat VA, Dhiman RK, Mishra A, Naik SR. Correlation of 24-h esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. Dig Dis Sci 1994; 39: 199–205
   PubMed Web of Science ®Google Scholar
• Bowrey DJ, Williams GT, Clark GW. Histological changes in the oesophageal squamous mucosa: correlation with ambulatory 24 hour pH monitoring. J Clin Pathol 2003; 56: 205–8
   PubMed Web of Science ®Google Scholar
• Adachi K, Fujishiro H, Katsube T, Yuki M, Ono M, Kawamura A, et al. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis. J Gastroenterol Hepatol 2001; 16: 1191–6
   PubMed Web of Science ®Google Scholar
• Jalal A, Payne HR, Jeyasingham K. The influence of age on gastro-oesophageal reflux: a re-appraisal of the DeMeester scoring system. Eur J Cardiothorac Surg 2000; 18: 411–7
   PubMed Web of Science ®Google Scholar
• Freeland GR, Higgs RH, Castell DO, McGuigan JE. Lower esophageal sphincter and gastric acid response to intravenous infusions of synthetic human gastrin I heptadecapeptide. Gastroenterology 1976; 71: 570–4
   PubMed Web of Science ®Google Scholar
• Corazziari E, Pozzessere C, Dani S, Anzini F, Torsoli A. Lower oesophageal sphincter response to intravenous infusions of pentagastrin in normal subjects, antrectomised and achalasic patients. Gut 1978; 19: 1121–4
   PubMed Web of Science ®Google Scholar
• Kravitz JJ, Snape WJ, Jr, Cohen S. Effect of histamine and histamine antagonists on human lower esophageal sphincter function. Gastroenterology 1978; 74: 435–40
   PubMed Web of Science ®Google Scholar
• Bozymski EM. Pathophysiology and diagnosis of gastroesophageal reflux disease. Am J Hosp Pharm 1993; 50: S4–6
   Google Scholar
• Achem AC, Achem SR, Stark ME, DeVault KR. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure. Am J Gastroenterol 2003; 98: 35–9
   PubMed Web of Science ®Google Scholar
• Wang H, Liu B. The relationship between lower esophageal sphincter motility and function with gastroesophageal reflux disease. Zhonghua Nei Ke Za Zhi 2004; 43: 750–2
   PubMedGoogle Scholar
• Richter J. Do we know the cause of reflux disease?. Eur J Gastroenterol Hepatol 1999; 11 Suppl 1: S3–9
   Google Scholar
• Kasapidis P, Xynos E, Mantides A, Chrysos E, Demonakou M, Nikolopoulos N, et al. Differences in manometry and 24-h ambulatory pH-metry between patients with and without endoscopic or histological esophagitis in gastroesophageal reflux disease. Am J Gastroenterol 1993; 88: 1893–9
   PubMed Web of Science ®Google Scholar
• Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ. Double-blind comparison of rabeprazole 20 mg vs omeprazole 20 mg in the treatment of erosive or ulcerative gastro-esophageal reflux disease. Aliment Pharmacol Ther 1999; 13: 49–57
   PubMed Web of Science ®Google Scholar
• Castell DO. Nocturnal acid breakthrough in perspective: let's not throw out the baby with the bath water. Am J Gastroenterol 2003; 98: 517–8
   PubMed Web of Science ®Google Scholar
• Leite LP, Johnston BT, Just RJ, Castell DO. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996; 91: 1527–31
   PubMed Web of Science ®Google Scholar
• Katzka DA, Paoletti V, Leite L, Castell DO. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 1996; 91: 2110–13
   PubMed Web of Science ®Google Scholar
• Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 1998; 115: 1335–9
   PubMed Web of Science ®Google Scholar
• Katz PO, Anderson C, Khoury R, Castell DO. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther 1998; 12: 1231–4
   PubMed Web of Science ®Google Scholar
• Xue S, Katz PO, Banerjee P, Tutuian R, Castell DO. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther 2001; 15: 1351–6
   PubMed Web of Science ®Google Scholar